Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Kromek Group Plc Rises 5.98% as Investor Interest Builds on Medical-imaging detector product range

Kromek Group Plc advanced 5.98% as investors responded positively to the company's continued progress on its radiation and X-ray detector technology. The move places the stock among the stronger performers within the healthcare sector for the session.

Ankur Sharma | 01 September 2026

Reckitt Benckiser Group plc Rises 4.87% as Investor Interest Builds on Core consumer-health brand portfolio

Reckitt Benckiser Group plc advanced 4.87% as investors responded positively to the company's continued progress on its a portfolio of consumer health, hygiene and nutrition brands. The move places the stock among the stronger performers within the healthcare sector for the session.

Ankur Sharma | 01 September 2026

Sareum Holdings plc Rises 4.48% as Investor Interest Builds on Lead kinase-inhibitor drug-development programme

Sareum Holdings plc advanced 4.48% as investors responded positively to the company's continued progress on its a pipeline of oncology and immunology drug candidates. The move places the stock among the stronger performers within the healthcare sector for the session.

Ankur Sharma | 01 September 2026

Provexis PLC Shares Rise 6.86%: Fruitflow Growth and September Results Put LSE:PXS in Focus

Provexis PLC (LSE:PXS) has attracted renewed attention after its shares moved6.86% higher on 1 September 2026. For a relatively small company with aMarket Capitalisationin the tens of millions of pounds and a comparatively limited trading history on many sessions, a percentage move of this …

Ankur Sharma | 01 September 2026

Reckitt Benckiser LSE:RKT Surges 4.5%: US Litigation Win Puts Stock Back in Focus

Reckitt Benckiser has become one of the most closely watched UK consumer-health stocks afterLSE:RKT rose approximately 4.5% on 1 September 2026.

Ankur Sharma | 01 September 2026

Oxford BioDynamics Stock Jumps 8.33%: New Funding, CEO Strategy and EpiSwitch Growth in Focus

Oxford BioDynamics Plc has emerged as one of the notable percentage gainers among small UK healthcare shares, withLSE:OBD gaining 8.33% on 1 September 2026.

Ankur Sharma | 01 September 2026

ImmuPharma PLC (LSE:IMM) Stock Surges 13.80%: Kapiglucagon Development Milestones Create Fresh Investor Interest

ImmuPharma PLC (LSE:IMM) has attracted renewed investor attention after recording a13.80% gain on 1 September 2026.

Ankur Sharma | 01 September 2026

Why Are Investors Watching Ondine Biomedical Today? LSE:OBI Gains 10.64% After Clinical Trial Milestone

Ondine Biomedical has become one of the most closely watched small-cap healthcare names on the London market after announcing a major clinical milestone on 1 September 2026.

Ankur Sharma | 01 September 2026

Abingdon Health Plc Rises 4.55% as Investor Interest Builds on Core lateral-flow diagnostics manufacturing business

Abingdon Health Plc advanced 4.55% as investors responded positively to the company's continued progress on its rapid diagnostic-test development and manufacturing capabilities. The move places the stock among the stronger performers within the healthcare sector for the session.

Ankur Sharma | 01 September 2026

Oxford Nanopore Technologies Tumbles: Sequencing Pioneer Hits a Rough Patch

Oxford Nanopore Technologies (LSE:ONT) shares fell 13.50p to 162.60p, a decline of 7.67% on the day, leaving the company valued at roughly £1,717.62m. The fall places the stock among the day's more significant decliners on the London market. As with many growth-stage technology and …

Divya Sood | 01 September 2026
Support

Hi! How can we help you today?

Loading…